Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008

NCT02955693 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: LAS41008 120 mg / Fumaderm® 120 mg

Sponsor

Almirall, S.A.